CONMED Corp — Director's Dealing 2013

Mar 6, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-03-05

Reporting Person: SHALLISH ROBERT D JR (Vice President/Finance/CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-03-05	Common Stock	M	10000	$19.93	Acquired	44391	Direct
2013-03-05	Common Stock	F	7773	$30.63	Disposed	36618	Direct
2013-03-05	Common Stock	M	6000	$16.46	Acquired	42618	Direct
2013-03-05	Common Stock	F	4231	$30.63	Disposed	38387	Direct
2013-03-05	Common Stock	M	5600	$19.26	Acquired	43987	Direct
2013-03-05	Common Stock	F	4275	$30.63	Disposed	39712	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-05	Sars (Stock Appreciation Rights)	$19.93	M	10000	Disposed	2016-05-16	Common Stock (10000)	Direct
2013-03-05	Sars (Stock Appreciation Rights)	$16.46	M	6000	Disposed	2019-06-01	Common Stock (6000)	Direct
2013-03-05	Sars (Stock Appreciation Rights)	$19.26	M	5600	Disposed	2020-06-01	Common Stock (5600)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.